Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luc Biedermann

Showing results (101-110 of 201) with videos related to

Pageof 21
Sort By:
European Journal of Gastroenterology & Hepatology|August 3, 2016
Cytomegalovirus disease in inflammatory bowel disease: epidemiology and disease characteristics in a large single-centre experienceJonas Bontà, Jonas Zeitz, Pascal Frei, et al.
Plos One|July 3, 2018
The presence of genetic risk variants within PTPN2 and PTPN22 is associated with intestinal microbiota alterations in Swiss IBD cohort patientsBahtiyar Yilmaz, Marianne R Spalinger, Luc Biedermann, et al.
International Archives of Allergy and Immunology|December 23, 2019
Systematic Assessment of Adult Patients' Satisfaction with Various Eosinophilic Esophagitis TherapiesEkaterina Safroneeva, David Hafner, Claudia E Kuehni, et al.
World Journal of Gastrointestinal Surgery|March 1, 2021
Perianal fistulodesis - A pilot study of a novel minimally invasive surgical and medical approach for closure of perianal fistulaeRoxanne Villiger, Daniela Cabalzar-Wondberg, Daniela Zeller, et al.
European Journal of Gastroenterology & Hepatology|November 24, 2016
Patients' views on fecal microbiota transplantation: an acceptable therapeutic option in inflammatory bowel disease?Jonas Zeitz, Marina Bissig, Christiane Barthel, et al.
Digestive Diseases (Basel, Switzerland)|May 26, 2023
Barrett's Esophagus in Eosinophilic Esophagitis in Swiss Eosinophilic Esophagitis Cohort Study (SEECS)Roger Scherer, Philipp Schreiner, Jean-Benoit Rossel, et al.
BMC Gastroenterology|August 4, 2021
Genotype-phenotype associations of polymorphisms within the gene locus of NOD-like receptor pyrin domain containing 3 in Swiss inflammatory bowel disease patientsPriyatharsan Yoganathan, Jean-Benoit Rossel, Sebastian Bruno Ulrich Jordi, et al.
Digestion|June 20, 2016
Malignancies in Patients with Inflammatory Bowel Disease: A Single-Centre ExperienceMehdi Madanchi, Jonas Zeitz, Christiane Barthel, et al.
Nutrition Journal|August 13, 2015
Patients' perceptions on the impact of coffee consumption in inflammatory bowel disease: friend or foe?--a patient surveyChristiane Barthel, Sandra Wiegand, Sylvie Scharl, et al.
The American Journal of Gastroenterology|March 31, 2025
Loss of Response to Off-Label Swallowed Topical Corticosteroids in Eosinophilic Esophagitis Can be Overcome by a Switch to an Esophageal-Targeted Budesonide FormulationFritz R Murray, Jean-Benoit Rossel, Ekaterina Safroneeva, et al.
Pageof 21

Showing results (101-110 of 201) with videos related to

Sort By:
Pageof 21
European Journal of Gastroenterology & Hepatology|August 3, 2016
Cytomegalovirus disease in inflammatory bowel disease: epidemiology and disease characteristics in a large single-centre experienceJonas Bontà, Jonas Zeitz, Pascal Frei, et al.
Plos One|July 3, 2018
The presence of genetic risk variants within PTPN2 and PTPN22 is associated with intestinal microbiota alterations in Swiss IBD cohort patientsBahtiyar Yilmaz, Marianne R Spalinger, Luc Biedermann, et al.
International Archives of Allergy and Immunology|December 23, 2019
Systematic Assessment of Adult Patients' Satisfaction with Various Eosinophilic Esophagitis TherapiesEkaterina Safroneeva, David Hafner, Claudia E Kuehni, et al.
World Journal of Gastrointestinal Surgery|March 1, 2021
Perianal fistulodesis - A pilot study of a novel minimally invasive surgical and medical approach for closure of perianal fistulaeRoxanne Villiger, Daniela Cabalzar-Wondberg, Daniela Zeller, et al.
European Journal of Gastroenterology & Hepatology|November 24, 2016
Patients' views on fecal microbiota transplantation: an acceptable therapeutic option in inflammatory bowel disease?Jonas Zeitz, Marina Bissig, Christiane Barthel, et al.
Digestive Diseases (Basel, Switzerland)|May 26, 2023
Barrett's Esophagus in Eosinophilic Esophagitis in Swiss Eosinophilic Esophagitis Cohort Study (SEECS)Roger Scherer, Philipp Schreiner, Jean-Benoit Rossel, et al.
BMC Gastroenterology|August 4, 2021
Genotype-phenotype associations of polymorphisms within the gene locus of NOD-like receptor pyrin domain containing 3 in Swiss inflammatory bowel disease patientsPriyatharsan Yoganathan, Jean-Benoit Rossel, Sebastian Bruno Ulrich Jordi, et al.
Digestion|June 20, 2016
Malignancies in Patients with Inflammatory Bowel Disease: A Single-Centre ExperienceMehdi Madanchi, Jonas Zeitz, Christiane Barthel, et al.
Nutrition Journal|August 13, 2015
Patients' perceptions on the impact of coffee consumption in inflammatory bowel disease: friend or foe?--a patient surveyChristiane Barthel, Sandra Wiegand, Sylvie Scharl, et al.
The American Journal of Gastroenterology|March 31, 2025
Loss of Response to Off-Label Swallowed Topical Corticosteroids in Eosinophilic Esophagitis Can be Overcome by a Switch to an Esophageal-Targeted Budesonide FormulationFritz R Murray, Jean-Benoit Rossel, Ekaterina Safroneeva, et al.
Pageof 21